Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Intercept Pharmaceuticals (ICPT)

Intercept Pharmaceuticals (ICPT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,109,308
  • Shares Outstanding, K 32,733
  • Annual Sales, $ 179,800 K
  • Annual Income, $ -309,240 K
  • 60-Month Beta 1.74
  • Price/Sales 12.40
  • Price/Cash Flow N/A
  • Price/Book 23.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -2.52
  • Number of Estimates 10
  • High Estimate -1.70
  • Low Estimate -2.92
  • Prior Year -2.97
  • Growth Rate Est. (year over year) +15.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
90.93 +4.46%
on 01/31/20
102.06 -6.93%
on 01/22/20
-5.75 (-5.71%)
since 01/21/20
3-Month
87.55 +8.50%
on 11/22/19
125.00 -24.01%
on 12/31/19
+7.09 (+8.07%)
since 11/21/19
52-Week
56.76 +67.35%
on 10/10/19
125.00 -24.01%
on 12/31/19
+3.16 (+3.44%)
since 02/21/19

Most Recent Stories

More News
Molecular Partners Announces Newly Nominated Board Members for Upcoming Annual Meeting

Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of drugs known as DARPin® therapies, today announced the nomination of three new board members, proposed...

ICPT : 94.99 (+1.15%)
NVS : 96.76 (+0.49%)
Intercept to Announce Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce...

ICPT : 94.99 (+1.15%)
16.1% Return Seen to Date on SmarTrend Intercept Pharma Call (ICPT)

SmarTrend identified a Downtrend for Intercept Pharma (NASDAQ:ICPT) on January 6th, 2020 at $113.52. In approximately 1 month, Intercept Pharma has returned 16.12% as of today's recent price of $95.22....

ICPT : 94.99 (+1.15%)
Intercept (ICPT) Concludes Enrollment in Study on NASH Drug

Intercept (ICPT) closes enrollment in late-stage study evaluating obeticholic acid for the treatment of compensated cirrhosis due to nonalcoholic steatohepatitis.

RGEN : 98.11 (-2.98%)
ICPT : 94.99 (+1.15%)
KALA : 6.50 (-0.46%)
DNLI : 24.45 (-1.29%)
Intercept Completes Enrollment of Phase 3 REVERSE Study Evaluating Obeticholic Acid for the Treatment of Compensated Cirrhosis due to NASH

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

ICPT : 94.99 (+1.15%)
Intercept Pharma Shares Down 17.1% Since SmarTrend's Sell Call (ICPT)

SmarTrend identified a Downtrend for Intercept Pharma (NASDAQ:ICPT) on January 6th, 2020 at $113.52. In approximately 3 weeks, Intercept Pharma has returned 17.11% as of today's recent price of $94.09....

ICPT : 94.99 (+1.15%)
Intercept Pharma Falls 2.43% on Heavy Volume: Watch For Potential Rebound

Intercept Pharma (NASDAQ:ICPT) traded in a range yesterday that spanned from a low of $103.14 to a high of $105.56. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of...

ICPT : 94.99 (+1.15%)
Intercept Pharma Set to Possibly Pullback After Yesterday's Rally of 1.40%

Intercept Pharma (NASDAQ:ICPT) traded in a range yesterday that spanned from a low of $117.44 to a high of $119.19. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

ICPT : 94.99 (+1.15%)
Passage Bio Appoints Sandip Kapadia to Board of Directors

Passage Bio, a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system diseases, today announced the appointment of Sandip Kapadia to its board...

ICPT : 94.99 (+1.15%)
Intercept to Present at the 38th Annual J.P. Morgan Healthcare Conference

Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced...

JPM : 135.81 (-1.22%)
ICPT : 94.99 (+1.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ICPT with:

Business Summary

Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR)....

See More

Key Turning Points

2nd Resistance Point 99.39
1st Resistance Point 97.19
Last Price 94.99
1st Support Level 93.33
2nd Support Level 91.67

See More

52-Week High 125.00
Fibonacci 61.8% 98.93
Last Price 94.99
Fibonacci 50% 90.88
Fibonacci 38.2% 82.83
52-Week Low 56.76

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar